Jim Tananbaum Contributions to Foresite Capital

Foresite Capital, a healthcare venture firm recently announced the introduction of Molly He, Ph.D. as a venture partner.Dr. Molly previously worked as a senior director at Illumina. Hehasover 15 years of experience genomic research development and in the pharmaceutical industry. Jim Tananbaum said that Dr. Molly is one of the respected scientific researchers who will bring progress to Foresite capital.

Foresite Capital (see the company’s Facebook page) will expand its portfolio of transformational companies with the experience of Dr. He. Molly has a remarkable record of leadership and her extensive knowledge in genomics, and drug development will help the company. At Illumina, she was responsible for global protein reagent innovation and improvements. Before Illumina, Dr. Molly worked at Pacific Biosciences as the head of protein reagent development.

Starting her career journey, she worked the pharmaceutical industry for ten years. She was responsible for designing structural based antibody and small molecular drugs for immune diseases and cancer. Dr. Molly HE graduated from Nankai University with a degree in biochemistry. She then earned her Ph.D., in protein biophysics from the University of California.

She has published over20 papers and holds over 20 patent applications. With all these knowledge, Dr. Molly He will significantly benefit Foresite Capital. Dr. He said that she is privileged to be a partner because Foresite Capital usually invests in innovative companies in healthcare.

Jim Tananbaum is the founder and CEO of Foresite Capital which is located in San Francisco and another office in New York. Tananbaum has more than 20 years of practice in the health sector. He has invested in more than 20 successful healthcare companies. Jim graduated with an M.D from Harvard Medical School. Moreover, he graduated from Harvard Business School with an MBA. Also, he holds an undergraduate degree in Electrical engineering from Yale University.

Before graduating from Harvard medical school, Jim Tananbaum established GelTex Pharmaceuticals and was the founder and CEO of Theravance, Inc. Jim has worked with 21 healthcare companies like Jazzand Amira Pharmaceuticals. Foresite Capital provides growth capital to healthcare activities. Jim Tananbaum is passionate about improving thehealthcare business.